White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling ...

A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...

Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year ...

Kawhi Leonard has been one of the very best players of his generation, but few would have seen greatness in him when he was about to enter the NBA. Leonard was viewed as a solid but ...

Los Angeles Clippers star Kawhi Leonard on Saturday had nothing but kind words for his former head coach Gregg Popovich. On Friday, Popovich announced that he was stepping down as the head coach ...

The company anticipates multiple U.S. regulatory approvals in 2025. Despite the earnings miss, Regeneron remains focused on its strategic goals, with CEO Leonard Schleifer emphasizing the company’s ...

Now this one’s special to me because Regeneron’s co-founder and CEO, Dr. Len Schleifer, he was one of the first guests who ever came on the show back in April 12th, 2005. The stock was trading ...

An archive and transcript of this call will be available on Regeneron's Investor Relations website shortly after the call ends. Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...

Regeneron paid roughly $500 per share in the $5 billion Sanofi share repurchase, which now appears quite positive relative to our valuation. Founder Leonard Schleifer has led Regeneron as chief ...